SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/22 Clarus Theraps Holdings, Inc. 10-K 12/31/21 89:9M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.27M 2: EX-4.1 Instrument Defining the Rights of Security Holders HTML 64K 3: EX-23.1 Consent of Expert or Counsel HTML 23K 4: EX-31.1 Certification -- §302 - SOA'02 HTML 30K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 30K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 25K 7: EX-32.2 Certification -- §906 - SOA'02 HTML 25K 13: R1 Cover Page HTML 101K 14: R2 Consolidated Balance Sheets HTML 119K 15: R3 Consolidated Balance Sheets (Parentheticals) HTML 48K 16: R4 Consolidated Statements of Operations HTML 113K 17: R5 Consolidated Statements of Redeemable Convertible HTML 80K Preferred Stock and Stockholders' Deficit 18: R6 Consolidated Statements of Cash Flows HTML 118K 19: R7 Organization and Description of Business HTML 50K Operations 20: R8 Summary of Significant Accounting Policies HTML 88K 21: R9 Business Combination HTML 50K 22: R10 Fair Value Measurements HTML 80K 23: R11 Inventory HTML 35K 24: R12 Property and Equipment HTML 37K 25: R13 Accrued Expenses HTML 35K 26: R14 Debt HTML 65K 27: R15 Stockholders' Equity (Deficit) HTML 67K 28: R16 Stock Based Compensation HTML 74K 29: R17 Income Taxes HTML 76K 30: R18 License Agreements HTML 30K 31: R19 Commitments & Contingencies HTML 36K 32: R20 Net Income (Loss) Per Share HTML 72K 33: R21 Related Party Transactions HTML 30K 34: R22 Subsequent Events HTML 28K 35: R23 Accounting Policies, by Policy (Policies) HTML 146K 36: R24 Summary of Significant Accounting Policies HTML 50K (Tables) 37: R25 Business Combination (Tables) HTML 47K 38: R26 Fair Value Measurements (Tables) HTML 76K 39: R27 Inventory (Tables) HTML 37K 40: R28 Property and Equipment (Tables) HTML 36K 41: R29 Accrued Expenses (Tables) HTML 34K 42: R30 Debt (Tables) HTML 48K 43: R31 Stockholders' Equity (Deficit) (Tables) HTML 54K 44: R32 Stock Based Compensation (Tables) HTML 74K 45: R33 Income Taxes (Tables) HTML 71K 46: R34 Net Income (Loss) Per Share (Tables) HTML 72K 47: R35 Organization and Description of Business HTML 91K Operations (Detail) 48: R36 Summary of Significant Accounting Policies HTML 34K (Details) 49: R37 Summary of Significant Accounting Policies HTML 30K (Details)- Property and Equipment, net 50: R38 Summary of Significant Accounting Policies HTML 31K (Details) - Summary of the deferred revenue contract liability (Detail) 51: R39 Business Combination - Summary Of Net Proceeds HTML 32K From The Business Combination (Details) 52: R40 Business Combination - Summary Of Common Stock HTML 42K Issued In Consummation Of Business Combination (Details) 53: R41 Business Combination - Summary of Impact of the HTML 40K transaction on the condensed consolidated statement of stockholder's equity (Details) 54: R42 Business Combination (Details) HTML 65K 55: R43 Fair Value Measurements (Details) HTML 80K 56: R44 Fair Value Measurements (Details) - Schedule of HTML 45K fair value hierarchy 57: R45 Fair Value Measurements (Details) - Schedule of HTML 31K changes in the fair value of the Company's warrant liability 58: R46 Fair Value Measurements - Schedule of simulation HTML 37K model for the private placement warrants and public warrants (Details) 59: R47 Inventory (Details) - Schedule of inventory HTML 37K 60: R48 Property and Equipment, net (Details) HTML 27K 61: R49 Property and Equipment, net (Details) - Schedule HTML 38K of property and equipment 62: R50 Accrued Expenses (Details) - Schedule of accrued HTML 33K expenses 63: R51 Debt (Details) HTML 192K 64: R52 Debt (Details) - Schedule of carrying value HTML 33K convertible notes consisted 65: R53 Debt (Details) - Schedule of senior secured notes HTML 37K 66: R54 Debt (Details) - Schedule of future principal HTML 34K payments of the senior secured notes 67: R55 Stockholders' Equity (Deficit) (Details) HTML 87K 68: R56 Stockholders' Equity (Deficit)- Schedule of HTML 53K redeemable convertible preferred stock (Detail) 69: R57 Stock Based Compensation (Details) HTML 79K 70: R58 Stock-Based Compensation (Details) - Schedule of HTML 35K weighted-average assumptions 71: R59 Stock Based Compensation (Details) - Schedule of HTML 35K stock-based compensation expense 72: R60 Stock Based Compensation - Summary of Restricted HTML 36K Common Stock Activity (Detail) 73: R61 Stock Based Compensation (Details) - Schedule of HTML 61K stock option activity under the Plans 74: R62 Income Taxes (Details) HTML 43K 75: R63 Income Taxes (Details) - Schedule of net deferred HTML 46K tax assets 76: R64 Income Taxes (Details) - Schedule of effective HTML 68K income tax rate 77: R65 Income Taxes (Details) - Schedule of company's HTML 31K valuation allowance 78: R66 License Agreements (Details) HTML 36K 79: R67 Commitments & Contingencies (Details) HTML 44K 80: R68 Net Income (Loss) Per Share (Details) - Schedule HTML 78K of basic and diluted earnings (loss) per share attributable to common stockholders 81: R69 Net Income (Loss) Per Share (Details) - Schedule HTML 29K of basic and diluted earnings (Loss) Per Share Attributable to Common Stockholders (Parenthetical) 82: R70 Net Income (Loss) Per Share (Details) - Schedule HTML 40K of computation of diluted net loss per share attributable to common stockholders 83: R71 Related Party Transactions (Details) HTML 31K 84: R72 Subsequent Events (Details) HTML 36K 87: XML IDEA XML File -- Filing Summary XML 166K 85: XML XBRL Instance -- d288074d10k_htm XML 1.58M 86: EXCEL IDEA Workbook of Financial Reports XLSX 111K 9: EX-101.CAL XBRL Calculations -- crxt-20211231_cal XML 124K 10: EX-101.DEF XBRL Definitions -- crxt-20211231_def XML 1.01M 11: EX-101.LAB XBRL Labels -- crxt-20211231_lab XML 1.43M 12: EX-101.PRE XBRL Presentations -- crxt-20211231_pre XML 1.20M 8: EX-101.SCH XBRL Schema -- crxt-20211231 XSD 259K 88: JSON XBRL Instance as JSON Data -- MetaLinks 453± 658K 89: ZIP XBRL Zipped Folder -- 0001193125-22-092120-xbrl Zip 430K
Download this Microsoft® Excel® .xlsx workbook |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/28/22 Clarus Theraps Holdings, Inc. 10-K/A 12/31/21 16:698K Donnelley … Solutions/FA 4/01/22 Clarus Theraps Holdings, Inc. POS AM 84:9.7M Donnelley … Solutions/FA 4/01/22 Clarus Theraps Holdings, Inc. POS AM 84:9.5M Donnelley … Solutions/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/17/21 Clarus Theraps Holdings, Inc. S-1 97:12M Donnelley … Solutions/FA 12/07/21 Clarus Theraps Holdings, Inc. 8-K:1,3,8,912/03/21 17:1.1M Donnelley … Solutions/FA 9/30/21 Clarus Theraps Holdings, Inc. S-1 126:13M EdgarAgents LLC/FA 9/29/21 Clarus Theraps Holdings, Inc. 8-K:1,2,9 9/28/21 12:280K EdgarAgents LLC/FA 9/15/21 Clarus Theraps Holdings, Inc. 8-K:1,2,3,4 9/09/21 26:2.8M EdgarAgents LLC/FA 7/23/21 Clarus Theraps Holdings, Inc. 424B3 1:15M EdgarAgents LLC/FA 7/19/21 Clarus Theraps Holdings, Inc. S-4/A 7/16/21 61:21M EdgarAgents LLC/FA 6/25/21 Clarus Theraps Holdings, Inc. S-4/A 72:24M EdgarAgents LLC/FA 5/03/21 Clarus Theraps Holdings, Inc. 8-K:1,9 4/27/21 9:1.1M EdgarAgents LLC/FA 12/21/20 Clarus Theraps Holdings, Inc. 8-K:1,3,5,812/15/20 11:819K EdgarAgents LLC/FA |